Service of Nuclear Medicine, Institut Claudius Regaud, Toulouse, France.
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):129-37. doi: 10.1007/s00259-011-1929-3. Epub 2011 Sep 10.
PET/CT using (18)F-FDG is a well-established diagnostic examination in oncology, cardiology and neurology. The clinical significance of nontumoral testicular uptake of FDG is unknown. Functional testicular imaging may have important clinical applications in the diagnosis and prognosis of male infertility. The aim of this study was to determine the andrological value of a FDG PET/CT in analysing testicular function, by correlating the PET/CT data with the sperm parameters.
Retrospective analysis of FDG PET/CT in 20 consecutive cancer patients without testicular pathology in whom two semen samples had been obtained for analysis before any chemotherapy. FDG PET/CT parameters were the mean standardized uptake value (SUVmean), used for measuring the intensity of uptake, and the functional testicular volume (FV). For statistical analysis, a Spearman's rank correlation test and a Mann-Whitney test were used.
Of 20 patients (mean age 22 years), 18 had provided two sperm samples for cryopreservation. Sperm concentration was above 20 × 10(6)/ml in 55% of the patients. The intensity of uptake and the FV were correlated with the total sperm count, the sperm concentration and motility (p < 0.05). The difference in SUVmean between the two testes showed an inverse correlation with sperm concentration (p = 0.036). Normospermic and oligospermic men had significant differences in: (1) mean SUVmean, (2) mean FV, and (3) the difference in intensity of uptake between the testes (p < 0.05).
This is the first report on the andrological value of FDG PET/CT in analysing nontumoral testicular function. This pilot study showed a significant correlation between intensity of uptake of FDG and testicular FV with the main sperm parameters. PET/CT with FDG could become a useful new tool in assisted reproductive technologies and other andrological or urological applications.
正电子发射断层扫描/计算机断层扫描(PET/CT)使用(18)F-氟脱氧葡萄糖(FDG)在肿瘤学、心脏病学和神经病学中是一种成熟的诊断检查方法。非肿瘤性睾丸摄取 FDG 的临床意义尚不清楚。功能性睾丸成像在男性不育症的诊断和预后中可能具有重要的临床应用价值。本研究旨在通过将 PET/CT 数据与精子参数相关联,确定 FDG PET/CT 在分析睾丸功能方面的男科价值。
回顾性分析 20 例连续癌症患者的 FDG PET/CT,这些患者没有睾丸病理学,并且在进行任何化疗之前已经获得了两份精液样本进行分析。FDG PET/CT 参数为平均标准化摄取值(SUVmean),用于测量摄取强度,以及功能性睾丸体积(FV)。统计分析采用 Spearman 秩相关检验和 Mann-Whitney 检验。
20 例患者(平均年龄 22 岁)中,18 例为冷冻保存提供了两份精液样本。55%的患者精子浓度高于 20×10(6)/ml。摄取强度和 FV 与总精子计数、精子浓度和活力呈正相关(p < 0.05)。两侧睾丸的 SUVmean 差异与精子浓度呈负相关(p = 0.036)。正常精子症和少精子症患者在以下方面存在显著差异:(1)平均 SUVmean,(2)平均 FV,以及(3)睾丸摄取强度差异(p < 0.05)。
这是首次报道 FDG PET/CT 在分析非肿瘤性睾丸功能方面的男科价值。这项初步研究表明,FDG 的摄取强度与睾丸 FV 与主要精子参数之间存在显著相关性。FDG 的 PET/CT 可能成为辅助生殖技术和其他男科或泌尿科应用的有用新工具。